Fulgent Genetics, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($5.3m) ($2.5m) ($5.6m) ($411k) $214.3m $507.4m $143.4m ($167.8m) ($42.7m) ($60.5m)
Net Income (Loss) Available to Common Stockholders, Basic ($13.7m) ($2.5m) ($167.8m) ($42.7m) ($60.5m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($5.6m) ($411k) $214.3m $506.2m $141.9m ($175.2m) ($43.8m) ($61.6m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($5.4m) ($2.5m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $41k
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $41k $0
Net Income (Loss) Attributable to Noncontrolling Interest ($1.1m) ($1.5m) ($7.4m) ($1.1m) ($1.1m)
Depreciation, Depletion and Amortization $1.2m $1.7m $2.2m $2.1m $3.0m $11.0m $32.7m $26.1m $24.9m $24.1m
Depreciation $1.2m $1.7m $2.2m $2.1m $3.0m $9.3m $25.5m $17.5m $16.4m $15.7m
Amortization of Intangible Assets $1.7m $6.5m $7.8m $8.0m $8.0m
Deferred Income Tax Expense (Benefit) $246k ($336k) $36k ($21k) ($1.8m) ($8.2m) ($8.3m) $11.5m ($3.7m) ($1.2m)
Share-based Payment Arrangement, Noncash Expense $4.7m $2.1m $2.3m $3.2m $8.2m $15.9m $32.6m $42.9m $44.5m $39.6m
Payment, Tax Withholding, Share-based Payment Arrangement $4.2m $1.8m $2.7m $2.9m $3.0m
Share-based Payment Arrangement, Expense $4.7m $2.1m $2.3m $3.2m $8.2m $15.9m $32.6m $42.9m $44.5m $39.6m
Equity Method Investment, Other than Temporary Impairment $4.4m
Goodwill, Impairment Loss $0 $120.2m $0 $0
Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss $692k $589k ($994k) $62k
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property ($5k) ($88k) ($11k) ($672k) ($850k) ($502k) ($305k) ($320k) $3k
Income (Loss) from Equity Method Investments ($524k) ($935k) ($777k) ($488k)
Income Tax Expense (Benefit) $920k ($1.0m) $36k $43k $72.5m $174.8m $42.1m $1.2m ($8.1m) ($8.4m)
Interest Expense Nonoperating ($170k) $75k
Operating Lease, Lease Income $145k $420k $281k $164k
Other Nonoperating Income (Expense) $561k $153k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $2.3m ($214k) $2.0m $839k $178.5m ($42.3m) ($68.6m) ($2.4m) $16.3m $23.3m
Increase (Decrease) in Accounts Payable $1.1m ($363k) $102k ($329k) $22.6m ($12.2m) ($25.3m) ($6.9m) $3.1m $550k
Proceeds from Stock Options Exercised $31k $15k $38k $104k $86k $31k $3k $51k $1k
General and Administrative Expense $4.6m $5.2m $5.5m $6.4m $15.2m $50.7m $111.1m $89.0m $88.1m $116.7m
Goodwill $50.9m $143.0m $22.1m $22.1m $25.1m
Investment Income, Interest $31.3m $30.9m
Nonoperating Income (Expense) $22.0m $21.1m
Operating Expenses $10.6m $13.7m $15.7m $18.8m $41.7m $101.1m $188.4m $300.0m $181.1m $222.0m
Restructuring Costs $3.0m
Net Cash Provided by (Used in) Operating Activities $4.4m $1.3m ($675k) $5.5m $140.6m $538.6m $253.5m $27.0m $21.1m ($101.6m)
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $3.8m $2.9m $2.3m $1.2m $35.1m $23.8m $18.8m $22.2m $40.3m $22.6m
Payments to Acquire Businesses, Net of Cash Acquired $61.9m $172.7m $399k $0 ($3.8m)
Net Cash Provided by (Used in) Investing Activities ($42.8m) ($2.0m) $950k ($29.0m) ($326.4m) ($546.5m) ($261.3m) $38.9m ($58.4m) $111.4m
Cash flows from financing activities:
Proceeds from Issuance of Common Stock $36.8m $28.8m $246.2m $89.5m
Payments for Repurchase of Common Stock $21k $62k $74.3m $25.1m $225k $10.9m
Proceeds from Noncontrolling Interests $10k
Net Cash Provided by (Used in) Financing Activities $45.8m ($770k) $15k $28.8m $261.3m $85.4m ($77.1m) ($47.8m) ($4.8m) ($14.8m)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $81k ($44k) ($17k) $20k $34k ($453k) ($149k) ($55k) $105k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $81k ($44k) $5.2m $75.5m $77.5m ($85.4m) $18.0m ($42.2m) ($5.0m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $246k $12.0m $87.4m $164.9m $79.5m $97.5m $55.3m $50.3m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $960k $512k $52k
Income Taxes Paid, Net $550k $757k $1k $20k $20.6m $237.1m $56.2m $3.3m $27.6m $96.4m